IBSA France
Fabrice JOVER is an experienced pharmaceutical executive currently serving as the General Manager of IBSA Pharma within the IBSA Group since December 2020, overseeing operations and in-house biotechnology research, specializing in various medical fields. Prior to this role, Fabrice held the position of Managing Director at JVR consulting, offering expertise in pharma, Medtech, and e-platforms. Fabrice's background includes a significant tenure at Aspen Pharma Group, where leadership involved global external affairs and strategic alliances, as well as serving as General Manager for France and Benelux. At GlaxoSmithKline, Fabrice advanced through various roles, ultimately directing a large sales and marketing team, while earlier career experience includes leadership positions at AstraZeneca, Bristol-Myers Squibb, Roussel-Uclaf (Sanofi), and roles in sales at GB-INNO-BM. Fabrice JOVER holds a PhD in Pharmacy, a Master in Business from ISG, and a Master's in Law focused on healthcare.
This person is not in any teams
IBSA France
IBSA Pharma S.A.S is the French subsidiary of IBSA, an international pharmaceutical group based in Switzerland. Created in 1987 under the Laboratoires Genevrier entity in the heart of Sophia-Antipolis, the first European technology park, IBSA Pharma has developed in 8 areas of specialization and provides patients and healthcare professionals with more than 100 pharmaceutical products, all manufactured in Europe according to the highest quality standards. Focused on innovation and driven by the desire to bring therapeutic alternatives to as many people as possible, the IBSA group is committed to improving the quality of life of patients by offering them health products in their best galenic form, for a proven and increased efficiency. IBSA Pharma is based on the 4 ethical and sustainable pillars of the group: #person, #innovation, # quality and # responsibility.